Xiamen Amoytop Biotech Co Ltd (688278) — Cash Flow Reinvestment Rate
Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow Reinvestment Rate of 0.37x as of September 2023, reinvesting CN¥122.64 Million (capex CN¥43.00 Million plus investments CN¥-79.64 Million) from operating cash flow of CN¥332.29 Million. See 688278 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiamen Amoytop Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Xiamen Amoytop Biotech Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Xiamen Amoytop Biotech Co Ltd.
Annual Cash Flow Reinvestment Rate for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Xiamen Amoytop Biotech Co Ltd. See Xiamen Amoytop Biotech Co Ltd (688278) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.30x | CN¥559.97 Million | CN¥430.63 Million | CN¥251.35 Million | ▲ +38.8% |
| 2023 | 0.94x | CN¥479.66 Million | CN¥512.10 Million | CN¥244.48 Million | ▼ -33.1% |
| 2022 | 1.40x | CN¥508.57 Million | CN¥363.16 Million | CN¥219.17 Million | ▲ +22.0% |
| 2021 | 1.15x | CN¥269.58 Million | CN¥234.78 Million | CN¥190.93 Million | ▼ -72.2% |
| 2020 | 4.14x | CN¥382.99 Million | CN¥92.61 Million | CN¥118.81 Million | ▲ +65.0% |
| 2019 | 2.51x | CN¥309.00 Million | CN¥123.30 Million | CN¥44.83 Million | ▼ -19.9% |
| 2018 | 3.13x | CN¥278.78 Million | CN¥89.15 Million | CN¥14.60 Million | ▼ -23.3% |
| 2016 | 4.08x | CN¥172.97 Million | CN¥42.43 Million | CN¥87.03 Million | — |